Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Biagini

Showing results (91-100 of 248) with videos related to

Pageof 25
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes|September 3, 2023
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-makingNathan Green, Yang Chen, Constantinos O'Mahony, et al.
The American Journal of Cardiology|March 10, 2009
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)Nevio Taglieri, Francesco Saia, Vincenzo Guiducci, et al.
Circulation|July 20, 2005
Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leafletsChris van der Lee, Folkert J ten Cate, Marcel L Geleijnse, et al.
European Heart Journal|October 16, 2013
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)Constantinos O'Mahony, Fatima Jichi, Menelaos Pavlou, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 6, 2007
Prognostic significance of akinesis becoming dyskinesis during dobutamine stress echocardiographyFabiola B Sozzi, Abdou Elhendy, Vittoria Rizzello, et al.
Coronary Artery Disease|July 9, 2004
Does resting two-dimensional echocardiography identify patients with ischemic cardiomyopathy and low likelihood of functional recovery after coronary revascularization?Vittoria Rizzello, Jeroen J Bax, Arend F L Schinkel, et al.
Giornale Italiano Di Cardiologia (2006)|March 28, 2022
[Mitral valve prolapse and mitral annulus disjunction: be aware of a potential arrhythmogenic substrate]Chiara Chiti, Vanda Parisi, Elisabetta Tonet, et al.
Giornale Italiano Di Cardiologia (2006)|August 30, 2022
[Ten questions about transthyretin amyloidosis]Alessandro Giovannetti, Antonella Accietto, Paolo Massa, et al.
Circulation. Arrhythmia and Electrophysiology|May 25, 2016
Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic CardiomyopathyConstantinos O'Mahony, Fatima Jichi, Lorenzo Monserrat, et al.
Frontiers in Pediatrics|February 11, 2022
Pediatric Restrictive CardiomyopathiesRaffaello Ditaranto, Angelo Giuseppe Caponetti, Valentina Ferrara, et al.
Pageof 25

Showing results (91-100 of 248) with videos related to

Sort By:
Pageof 25
European Heart Journal. Quality of Care & Clinical Outcomes|September 3, 2023
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-makingNathan Green, Yang Chen, Constantinos O'Mahony, et al.
The American Journal of Cardiology|March 10, 2009
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)Nevio Taglieri, Francesco Saia, Vincenzo Guiducci, et al.
Circulation|July 20, 2005
Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leafletsChris van der Lee, Folkert J ten Cate, Marcel L Geleijnse, et al.
European Heart Journal|October 16, 2013
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)Constantinos O'Mahony, Fatima Jichi, Menelaos Pavlou, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 6, 2007
Prognostic significance of akinesis becoming dyskinesis during dobutamine stress echocardiographyFabiola B Sozzi, Abdou Elhendy, Vittoria Rizzello, et al.
Coronary Artery Disease|July 9, 2004
Does resting two-dimensional echocardiography identify patients with ischemic cardiomyopathy and low likelihood of functional recovery after coronary revascularization?Vittoria Rizzello, Jeroen J Bax, Arend F L Schinkel, et al.
Giornale Italiano Di Cardiologia (2006)|March 28, 2022
[Mitral valve prolapse and mitral annulus disjunction: be aware of a potential arrhythmogenic substrate]Chiara Chiti, Vanda Parisi, Elisabetta Tonet, et al.
Giornale Italiano Di Cardiologia (2006)|August 30, 2022
[Ten questions about transthyretin amyloidosis]Alessandro Giovannetti, Antonella Accietto, Paolo Massa, et al.
Circulation. Arrhythmia and Electrophysiology|May 25, 2016
Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic CardiomyopathyConstantinos O'Mahony, Fatima Jichi, Lorenzo Monserrat, et al.
Frontiers in Pediatrics|February 11, 2022
Pediatric Restrictive CardiomyopathiesRaffaello Ditaranto, Angelo Giuseppe Caponetti, Valentina Ferrara, et al.
Pageof 25